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25Hydroxyvitamin D, 24hydroxylase was purified to an electrophoretically homogeneous state (M,=530001 from kid- 
ney mitochondria of female rats treated with vitamin 4. 
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1. INTRODUCTION 
25-Hydroxyvitamin D2 (calcidiol) 24-hydroxyl- 
ase is induced by 1,25_dihydroxyvitamin Dr (calci- 
triol) and is considered to function in the cata- 
bolism of the active form of vitamin Ds [ 11. In 
spite of such importance the enzyme has not so far 
been purified, though it was suggested to be a 
member of the cytochrome P450 superfamily [2,3]. 
In this communication we report the purification 
of this enzyme from rat kidney mitochondria. 
2. MATERIALS AND METHODS 
2.1. Materials 
25Hydroxyvitamin Ds, lcY,25dihydroxyvitamin Ds and 
24,25dihydroxyvitamin D3 were a gift from Chugai Phar- 
maceutical Co. (Tokyo, Japan). Pentyl-Sepharose was prepared 
according to the method described in [4]. TSK gel DEAE-SPW 
was purchased from Tosoh Co. (Tokyo, Japan). 
2.2, Purification of 25-hydroxyvitamin DS 24-hydroxylase 
All buffer solutions used in the following purification pro- 
cedures contained 20% glycerol, 1 /cg/ml leupeptin, and 
1 fig/ml pepstatin unless stated otherwise. Kidney mitochondria 
were prepared from female rats that received daily injections of 
50000 IU vitamin Ds for 1 week. Mitochondria were suspended 
in 15 mM Tris-HCl buffer @H 7.4) containing 0.19 M sucrose, 
0.5 mM l,Cdithiothreitol, 1 mM EDTA, sonicated and cen- 
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trifuged at 100000 x g for 1 h. The precipitate was suspended 
in 100 mM potassium phosphate buffer (pH 7.4) containing 
0.5 mM EDTA and 1 mM dithiothreitol. 10% cholate contain- 
ing 0.08qo Lubrol PX was added to the suspension under mild 
stirring to give a final cholate/protein ratio of 3 : 5 (w/w) and 
the solubilized, suspension was centrifuged at 100000 x g for 
1 h. The supernatant was applied to a pentyl-Sepharose 4B col- 
umn (2 x 13 cm) equilibrated with 100 mM phosphate buffer 
(pH 7.4) containing 0.4% sodium cholate, 0.5 mM EDTA, and 
1 mM dithiothreitol. The column was washed with equilibra- 
tion buffer and then eluted with 100 mM phosphate buffer con- 
taining 0.4% sodium cholate, 0.08% Lubrol, 1 mM EDTA, 
and 0.5 mM dithiothreitol. The fraction with the activity was 
collected and dialyzed against 30 mM phosphate buffer (PH 
7.4) containing 0.1 mM EDTA, 1 mM dithiothreitol, 0.4% 
sodium cholate and 0.03Yo Tween 20. The fraction was then ap- 
plied to a hydroxylapatite column (1.2 x 6.5 cm) equilibrated 
with the same buffer as used for dialysis. The column was wash- 
ed with 60 mM phosphate buffer (pH 7.4) containing 0.1 mM 
EDTA, 1 mM dithiothreitol, 0.4% sodium cholate and 0.05% 
Tween 20, and then eluted with 150 mM phosphate buffer. The 
fraction with the enzyme activity was collected and dialyzed 
against 35 mM Tris-HCl buffer (pH 7.4) containing 0.4 mM 
EDTA, 0.5 mM dithiothreitol, 0.1% Lubrol, 0.3% Tween 20 
and 0.05qo sodium cholate. From this step onwards protease in- 
hibitors were omitted and HPLC was performed at room 
temperature. Aliquots were injected into a TSK-gel 
DEAE-5PW column (7.5 x 75 mm) equilibrated with the 
dialyzing buffer. The column was eluted with linear NaCl gra- 
dients (O-70 min, O-O. 1 M; 70-100 min, 0.1-0.5 M). The flow 
rate was 0.4 ml/min, and the effluent was monitored at 
417 nm. 
2.3. Enzyme assay 
25-Hydroxyvitamin Ds 24-hydroxylase was assayed as 
follows. A typical mixture contained 2-50 pmol cytochrome 
P450, 2 nmol adrenodoxin, 0.05 U NADPH-adrenodoxin 
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reductase, 0.5 ymol EDTA, SOrmol Tris-HC1 (pH 7.7), 
0.5 prnol NADPH and 10 nmol 25-hydroxyvitamin DJ dissolv- 
ed in 5 pl ethanol in a final volume of 0.5 ml. The reaction was 
started by adding NADPH and incubated at 37°C. After 
5-7 min the reaction was terminated by adding 100 pl 1 N 
NaOH. The products were extracted by benzene. The solvent 
was evaporated under reduced pressure. The residue was 
dissolved in a mixture of chloroform and ethyl acetate (4: 1, 
v/v) and analyzed by HPLC using a Finepak Sil column (4.6 x 
250 mm, JASCO Co. Ltd, Tokyo) with a solvent mixture of 
isopropanol/methanol/hexane (6:6: 88, v/v) at a flow rate of 
1.4 ml/min. For identification of the products reversed-phase 
HPLC was also performed using a Finepak Sil Cl8 column with 
a solvent mixture of methanol/water (80: 20, v/v) at a flow rate 
of 1 ml/min. 
2.4. Other methods 
SDS-polyacrylamide gel electrophoresis was performed ac- 
cording to the method described [5] and the protein bands were 
visualized by silver staining [6]. Cytochrome P450 concentra- 
tion was determined by a reduced CO difference spectrum using 
an extinction coefficient of 91 mM_’ .cm-’ [7]. Protein concen- 
tration was determined by the method of Lowry et al. [8] or a 
modification thereof [9]. Periodate oxidation was carried out as 
described in [lo]. 
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Fig. 1. Separation of 25-hydroxyvitamin D1 24-hydroxylase by 
high performance anion-exchange chromatography. An aliquot 
of the eluate from the hydroxylapatite column with the catalytic 
activity was injected into a TSK-gel DEAE-5PW column (7.5 X 
75 mm). 
3. RESULTS 
3.1. Purification of 25-hydroxyvitamin DS 
24-hydroxylase 
Table 1 summarizes the results of the purifica- 
weight of the enzyme calculated from this elec- 
trophoretogram was 53000. That the major band 
on the electrophoretogram is the cytochrome 
responsible for 25-hydroxyvitamin D3 
24-hydroxylase was confirmed by Western blotting 
analysis with antibody raised against the purified 
enzyme, which inhibited the enzyme activity (data 
not shown). 
tion procedure. Overall purification from 
solubilized fraction of kidney mitochondria was 
315-fold. Fig.1 shows the separation of 
25-hydroxyvitamin D3 24-hydroxylase by HPLC. 
As shown in the figure the enzyme activity was 
observed only in one peak. An SDS-polyacrylamide 
gel electrophoretogram of the eluate from HPLC 
with the activity is shown in fig.2. The active frac- 
tion revealed a single major band. The molecular 
3.2. Absorption spectra of 2Shydroxyvitamin 03 
24-hydroxylase 
Absorption spectra of the oxidized form of 
25-hydroxyvitamin Ds 24-hydroxylase xhibited an 
intense Soret absorption peak at 417 nm and 2 
minor peaks at 535 and 570 nm (data not shown). 
The absorption maximum for the reduced CO 
complex was at 453 nm (fig.3). 
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Table 1 
Purification of 25-hydroxyvitamin D3 24-hydroxylase from rat kidney 
Purification Protein 
step (mg) 
Mitochondria 1104 
Membrane fraction 820 
Solubilized fraction 469 
Pentyl-Sepharose 23.4 
Hydroxylapatite 5.6 
DEAE-5PW 0.11 
Total 
P450 
(nmol) 
16.5 
5.0 
2.1 
0.29 
Specific 
content 
(nmol/mg 
protein) 
0.035 
0.21 
0.37 
2.8 
Total Specific 
activity activity 
(nmol/min) (nmol/min per 
mg protein) 
81 0.173 
43 1.85 
35 6.32 
5.7 54.6 
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Fig.2. SDS-polyacrylamide gel electrophoretogram of the 
HPLC fraction showing 25hydroxyvitamin Dp 24-hydroxylase 
activity. Migration was from top to bottom. The gel was stained 
with silver. Lane A, molecular weight standards (phosphorylase 
b: M, 94000; bovine serum albumin: A4,67000; ovalbumin: M, 
43000; carbonic anhydrase: A4, 30000); lane B, 
25-hydroxyvitamin Ds 24-hydroxylase (P450,,&; lane C, 
cytochrome P450,,25 (A4* 50000, [12]); lane D, cytochrome 
P45Ob in rat (kfr 52500); lane E, P45Oc (kfr 56000). The 
amounts of cytochromes P450 applied were 0.09 pg. 
3.3. Reconstitution of enzyme activity 
25-Hydroxyvitamin D3 24-hydroxylase activity 
was reconstituted with the purified cytochrome 
P450, adrenodoxin, NADPH-adrenodoxin reduc- 
tase, and NADPH. The omission of either 
cytochrome P450 or the electron-carrying system 
(adrenodoxin and NADPH-adrenodoxin reduc- 
tase) resulted in a complete loss of activity (table 
2). Liver microsomal NADPH-cytochrome P450 
reductase could not be substituted for the adrenal 
electron-transferring system. 
3 A. Identification of the reaction product 
Fig.4 shows a typical chromatogram obtained by 
the straight phase HPLC of the product obtained 
by incubating 25hydroxyvitamin D3 with the 
purified enzyme together with adrenodoxin and 
NADPH-adrenodoxin reductase. As shown in the 
figure a peak corresponding to 
24,25_dihydroxyvitamin D3 is clearly observed, 
whereas no peak is seen at a retention time cor- 
responding to lcu,25-dihydroxyvitamin D3. A 
similar result was also obtained with reversed- 
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Fig.3. CO difference spectrum of the renal mitochondrial 
25-hydroxyvitamin Ds 24-hydroxylase. The spectrum was 
measured with a sample containing 0.016~M cytochrome 
P450,,24 (5.7 cg protein/ml) in 0.1 M potassium phosphate 
buffer, pH 7.4, containing 20% glycerol and 1% Emulgen 913. 
phase HPLC (data not shown). When the product 
from HPLC was treated with periodate, the pro- 
duct could no longer be detected. 
Table 2 
Reconstitution of 2bhydroxylation of 25-hydroxyvitamin D3 
Reaction system Product 
(nmol/min per 
nmol of P450) 
Complete systema 
minus adrenodoxin 
minus NADPH-adrenodoxin reductase 
replacement of adrenodoxin and NADPH- 
adrenodoxin reductase with NADPH- 
cytochrome P450 reductase 
plus dilauroylglyceryl-3-phosphorylcholine 
19.7b 
N.D. 
N.D. 
N.D. 
31.5 
a The complete system contained, 2.4 pmol cytochrome P450, 
2 nmol adrenodoxin, 0.05 u NADPH-adrenodoxin 
reductase, 0.5pmol EDTA, 0.5 pmol NADPH, 10 nmol 
25-hydroxyvitamin D3 and 50,~mol Tris-HCl (PH 7.7) in a 
final volume of 0.5 ml. Incubation was conducted at 37°C for 
7 min 
b Turnover number is 22 min-’ when calculated from I’,,,, 
value 
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Fig.4. HPLC of the product obtained by incubating 
25hydroxyvitamin Dp in the reconstituted system using the 
purified P450,,~ (2.4 pmol). A, 24,25dihydrovitamin Ds 
(50 pmol); la,25_dihydroxyvitamin Ds (100 pmol). B, the 
incubation products. 
4. DISCUSSION 
We purified kidney mitochondrial cytochrome 
P450 catalyzing 25hydroxyvitamin D3 
24-hydroxylation to an electrophoretically 
homogeneous tate based on catalytic activity, and 
we clearly showed the enzyme to be cytochrome 
P450. The turnover number of the purified enzyme 
is 22 min-’ which is several thousand-fold higher 
than that reported so far [lo, 111. The present ex- 
periment also unequivocally solved the problem 
whether 24-hydroxylase and la-hydroxylase of 
25hydroxyvitamin D3 are similar. Since the 
purified enzyme does not catalyze llr- 
hydroxylation it is distinct from la-hydroxylase. 
Since this is the P450 isolated from this source for 
the first time, it may belong to a unique 
cytochrome P450 family, the amino acid structure 
of which is now under investigation. 
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